Detection of specific sequences in nucleic acids

• US 4,883,750 A
• Filed: 12/13/1984
• Issued: 11/28/1989
• Est. Priority Date: 12/13/1984
• Status: Expired due to Term

• Current Assignee: Applied Biosystems LLC (Thermo Fisher Scientific Incorporated)
• Original Assignee: Applied Biosystems, Inc. (Thermo Fisher Scientific Incorporated)
• Inventors: Hunkapiller, Michael W., Glazer, Alexander N., Whiteley, Norman M.
• Primary Examiner(s): Griffin, Ronald W.
• Assistant Examiner(s): Jay, Jeremy M.
• Application Number:
  US06/681,055
• Time in Patent Office: 1,811 Days
• Field of Search: 435/6, 435/803, 435/810, 435/7, 436/501, 436/811, 436/808, 935/78
• US Class Current: 435/6.16
• CPC Class Codes: C12Q 1/6816 characterised by the detection means C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/6862 Ligase chain reaction [LCR]
• CPC Class Codes: C12Q 2533/107 Probe or oligonucleotide ligation
• CPC Class Codes: C12Q 2563/131 the label being a member of a cognate binding pair, i.e. extends to antibodies, haptens, avidin
• CPC Class Codes: C12Q 2600/156 Polymorphic or mutational markers
• CPC Class Codes: Y10S 435/803 Physical recovery methods, e.g. chromatography, grinding
• CPC Class Codes: Y10S 436/811 Test for named disease, body condition or organ function

Abstract

The invention provides a method for diagnosis of genetic abnormalities or other genetic conditions which can be readily automated. The method is used to determine the presence or absence of a target sequence in a sample of denatured nucleic acid and entails hybridizing the sample with a probe complementary to a diagnostic portion of the target sequence (the diagnostic probe), and with a probe complementary to a nucleotide sequence contiguous with the diagnostic portion (the contiguous probe), under conditions wherein the diagnostic probe remains bound substantially only to the sample nucleic acid containing the target sequence. The diagnostic probe and contiguous probe are then covalently attached to yield a target probe which is complementary to the target sequence, and the probes which are not attached are removed. In the preferred mode, one of the probes is labeled so that the presence or absence of the target sequence can then be tested by melting the sample nucleic acid-target probe duplex, eluting the dissociated target probe, and testing for the label. In another embodiment, the testing is accomplished without first removing probes not covalently attached, by attaching a hook to the probe that is not labeled, so that the labeled target probe may be recovered by catching the hook. In both instances, the presence of both the diagnostic probe and the contiguous probe is required for the label to appear in the assay. The above method is then applied to the detection of genetic diseases.

Claims

1. A method of testing for the presence or absence of a target sequence in a sample containing DNA, the steps comprising:

(a) denaturing the sample DNA;

(b) treating the denatured DNA with a first probe which is complementary to a first portion of the target sequence to produce a duplex of first probe and denatured DNA;

(c) treating the duplex formed in step (b) with a second probe, which is shorter than the first probe and ligatable therewith, and which is complementary to the remaining portion of the target sequence;

(d) providing conditions for hybridization of the first probe and second probe to the target sequence in steps (b) and (c) wherein, by controlling stringency, the first probe does not bind substantially to the denature DNA which does not contain the first portion and wherein the second probe does not bind substantially to the denatured DNA which does not contain the remaining portion, the first probe and the second probe being of sufficient length that they can be stably hybridized to the target sequence long enough to be ligated to each other, and wherein at least one of the first and second probe is labeled;

(e) ligating first and second probe which are hybridized to the target sequence;

(f) removing unligated probe after step (e);

(g) testing for the presence of label.

2. A method of testing for the presence or absence of a target nucleotide sequence in a sample containing denatured nucleic acid, which method comprises:

(a) treating the denatured nucleic acid with a diagnostic probe complementary to a diagnostic portion of the target sequence, and with a contiguous probe complementary to a nucleotide sequence in the target sequence which is contiguous with the diagnostic portion, under conditions of stringency wherein the diagnostic probe and the contiguous probe would become hybridized to the denatured nucleic acid if the target sequence were present in the sample, said conditions of stringency such that the diagnostic probe remains bound substantially only to sample nucleic acid containing the target sequence, the diagnostic probe and the contiguous probe being of sufficient length to be able to stably hybridize to the target sequence long enough so that the diagnostic probe and the contiguous probe can be covalently attached to each other, and wherein at least one of the diagnostic and contiguous probes is labeled;

(b) covalently attaching the diagnostic probe to the contiguous probe after the sample has been treated with the diagnostic probe and the contiguous probe in step (a) to produce a target probe complementary to the target sequence;

(c) removing the probes not attached in step (b); and

(d) testing for the presence of label in the sample after step (c).

3. The method of claim 2 wherein the label is radioactive.

4. The method of claim 3 wherein the label is ³² P at the 5'"'"' terminus of one probe to be ligated to the 3'"'"' terminus of the other probe.

5. The method of claim 4 wherein step (d) of testing comprises measuring the amount of radioactivity present in the sample.

6. The method of claim 2 wherein step (d) of testing includes removing the target probe formed in step (b) and retaining any target probe so removed to provide a second sample.

7. The method of claim 6 wherein in the step of removing the target probe is eluted by increasing the stringency.

8. The method of claim 6 wherein in the step of removing, the target probe is eluted by using a temperature gradient.

9. The method of claim 2 wherein before step (d) a hook is attached to the unlabeled one of the diagnostic and contiguous probes.

10. The method of claim 9 wherein the target probe is removed in step (d) by catching the hook.

11. The method of claim 10 wherein the hook comprises a biotin moiety.

12. The method of claim 11 wherein the hook is caught by using streptavidin to bind the biotin moiety.

13. The method of claim 6 wherein the second sample is tested for the presence of label.

14. The method of claim 13 wherein the label is radioactive.

15. The method of claim 14 wherein the label is ³² P at the 5'"'"' terminus of one probe to be ligated to the 3'"'"' terminus of the other probe.

16. The method of claim 15 wherein step (d) of testing comprises measuring the amount of radioactivity present in the second sample.

17. A method of testing for the presence or absence of a target nucleotide sequence in a sample containing denatured nucleic acid using a diagnostic probe which is complementary to a diagnostic portion of the target sequence and a contiguous probe which is complementary to a portion of said target sequence which is contiguous with said diagnostic portion, wherein the diagnostic probe and the contiguous probe are of sufficient length that they can be stably hybridized to the target sequence long enough to be covalently attached to each other, and wherein one of the diagnostic probe and the contiguous probe will remain hybridized to the target sequence under a higher stringency than will the other, comprising the steps of:

(a) hybridizing the one of the diagnostic and contiguous probes which will remain bound to its complementary portion of the target sequence under the higher stringency, said one of the diagnostic and contiguous probes hereinafter called the HS probe;

(b) after Step (a) hybridizing the other of said diagnostic and contiguous probes which will remain bound to its complementary portion in the target sequence under conditions of lower stringency, said other of said diagnostic and contiguous probes hereinafter called the LS probe;

(c) removing a substantial portion of said diagnostic probe which is not perfectly bound;

(d) covalently attaching said LS probe and said HS probe where they are bound adjacent to each other to form a target probe complementary to said target sequence;

(e) removing probe not attached in step (d); and

(f) testing for the presence of target probe in the sample remaining after Step (e).

18. A method as in claim 17 wherein said diagnostic probe and said contiguous probe are ligatable to each other and wherein Step (d) is conducted using ligase.

19. A method as in claim 17 further comprising the step of:

(g) measuring the amount of target probe.

20. A method as in claim 19 wherein one of said diagnostic and contiguous probes contains a label and Step (f) includes detecting said label.

21. A method as in claim 20 wherein Step (f) comprises increasing the stringency to remove the target probe.

22. A method as in claim 21 wherein Step (f) further comprises measuring the amount of label removed in removing the target probe.

23. A method as in claim 18 wherein Step (d) comprises covalently attaching the 5'"'"' end of said diagnostic probe with the 3'"'"' end of said contiguous probe.

24. A method as in claim 23 wherein said diagnostic probe and said contiguous probe are ligatable to each other and wherein Step (d) is conducted using ligase.

25. A method as in claim 17 wherein Step (d) comprises covalently attaching the 5'"'"' end of the contiguous probe with the 3'"'"' end of the diagnostic probe.

26. A method as in claim 19 wherein said target sequence corresponds to a genetic mutation from a known normal sequence, said method further comprising the step of comparing said amount of target probe from Step (g) with a calibrated standard for nucleic acid known to have said genetic mutation.

27. A method of testing for the presence or absence of a target nucleotide sequence in a sample containing denatured nucleic acid, the steps comprising:

(a) treating the denatured nucleic acid with a diagnostic probe complementary to a diagnostic portion of the target sequence, and with a contiguous probe complementary to a nucleotide sequence in the target sequence which is contiguous with the diagnostic portion, under conditions wherein the diagnostic probe and the contiguous probe would become hybridized to the denatured nucleic acid if the target sequence were present in the sample, wherein at least one of the diagnostic and contiguous probes is labeled, wherein the diagnostic and contiguous probes can be covalently attached, wherein the diagnostic probe and the contiguous probe are of sufficient length to be stably hybridized to the target sequence long enough to be covalently attached to each other while they are hybridized to the target sequence, and wherein conditions of stringency are controlled so that said diagnostic probe is specifically bound;

(b) after step (a), treating the sample to covalently attach the diagnostic probe to the contiguous probe where they are adjacent on the target sequence, to produce a target probe complementary to the target sequence;

(c) removing the target probe formed in step (b) from the sample to form a second sample containing the target probe; and

(d) testing for the presence of label in the second sample.

28. The method of claim 27 wherein a hook is attached to the unlabeled one of the diagnostic and contiguous probes.

29. The method of claim 28 wherein the target probe is removed by catching the hook.

30. The method of claim 29 wherein the hook comprises a biotin moiety.

31. The method of claim 30 wherein the hook is caught by using streptavidin to bind the biotin moiety.